Respiratory Motion, a medical device manufacturer dedicated to non-invasive Respiratory Volume Monitoring, launched its new digital ExSpiron2Xi. The ExSpiron2Xi is a new digital platform of enhanced monitoring that falls in line with RM’s commitment to rapidly innovate leading-edge products and services that establish accurate and safe new products. Inspired Innovation is the fil rouge in RM’s culture of meeting customer needs.
The company’s new ExSpiron2Xi enhances the previously existing standalone technology to healthcare providers across the globe.
Laura Piccinini, Chief Executive Officer, Respiratory Motion, said: “The Proven Respiratory Sentry has a new formula, and I am proud of announcing the launch of our ExSpiron2Xi. Unique. Accurate. Confidence.”